COMPASS: Genomic Profiling Could Guide Treatment in Advanced Pancreatic Cancer
February 2nd 2018In this interview we discuss preliminary results of the COMPASS trial, which used whole-genome sequencing and RNA sequencing to analyze the tumors of patients with advanced pancreatic ductal adenocarcinoma to identify possible first-line treatments.